Moleculin Biotech (MBRX) Other Non Operating Income (2017 - 2026)
Moleculin Biotech (MBRX) posted quarterly Other Non Operating Income of -$50000.0 for Q4 2025, down 516.67% year-over-year from $12000.0 in Q4 2024, and down 412.5% quarter-over-quarter from $16000.0 in Q3 2025.
Moleculin Biotech (MBRX) Other Non Operating Income (2017 - 2026) Analysis & Trends
Moleculin Biotech's Other Non Operating Income history runs 9 years deep, the most recent figure standing at -$50000.0 for Q4 2025.
- In Q4 2025, Other Non Operating Income fell 516.67% year-over-year to -$50000.0; the TTM figure through Dec 2025 stood at -$21000.0 (down 148.84% YoY), while the FY2025 annual figure was -$20000.0, down 146.51% from the prior year.
- Other Non Operating Income for Q4 2025 stood at -$50000.0, down from $16000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $19000.0 in Q3 2022, with the low at -$50000.0 in Q4 2025.
- The 5-year median for Other Non Operating Income is $9500.0 (2021), against an average of $7500.0.
- The sharpest annual moves came in 2023 and 2025: Other Non Operating Income surged 1700.0% in 2023, then slumped 516.67% in 2025.
- Moleculin Biotech's Other Non Operating Income stood at $10000.0 in 2021, then sank by 90.0% to $1000.0 in 2022, then soared by 1700.0% to $18000.0 in 2023, then plunged by 33.33% to $12000.0 in 2024, then plunged by 516.67% to -$50000.0 in 2025.
- Business Quant data shows MBRX's Other Non Operating Income at -$50000.0 in Q4 2025, $16000.0 in Q3 2025, and $4000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Moleculin Biotech | 3.37 Mn | 3.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13,000.00 |
| Dec 31, 2025 | -50,000.00 |
| Sep 30, 2025 | 16,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 9,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | 18,000.00 |
| Sep 30, 2023 | 13,000.00 |
| Jun 30, 2023 | 9,000.00 |
| Mar 31, 2023 | 8,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Sep 30, 2022 | 19,000.00 |
| Jun 30, 2022 | 15,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Jun 30, 2021 | 8,000.00 |